Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Janssen Research & Development, LLC
Inmune Bio, Inc.
AbbVie
Takeda
AbbVie
Janssen Research & Development, LLC
Massive Bio, Inc.
Constellation Pharmaceuticals
PharmaEssentia
AbbVie
Cogent Biosciences, Inc.
Hikma Pharmaceuticals LLC
AbbVie
Taproot Health
GlaxoSmithKline
Takeda
Amgen
GlaxoSmithKline
AbbVie
AbbVie
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
AbbVie
Asana BioSciences
GlaxoSmithKline
Takeda
Takeda
Novartis
Celgene
LEO Pharma
Celgene
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
Xian-Janssen Pharmaceutical Ltd.
Humanigen, Inc.
Ariad Pharmaceuticals
INSYS Therapeutics Inc
Eisai Inc.
Chroma Therapeutics
Sanofi